Management guide for COVID19 patients in intensive therapy - Hospital Pablo Arturo Suárez

Authors

DOI:

https://doi.org/10.29076/issn.2528-7737vol14iss35.2021pp92-107p

Keywords:

COVID-19, ICU, treatment, SARS Cov-2, guidelines

Abstract

On December 31, in Wuhan-China, it was reported that 27 people had been diagnosed with pneumonia of unknown cause, on January 7, 2020, Chinese scientists isolated the virus that causes the disease, a beta coronavirus that was called SARS- CoV-2. On March 11, 2020, the WHO declares COVID-19 a pandemic. In Ecuador, the first confirmed case of coronavirus was announced on February 29, and on March 13, the first death from COVID-19 was registered in the country. In Quito, the first public health hospital to receive infected patients was the Pablo Arturo Suárez Hospital. On April 1, 2020, the intensive care unit receives its first patient; For this, structural changes were made to have a center with level 3 biosecurity and a management protocol was drawn up; Therefore, it is relevant to say that in the face of a new and unknown entity, the application of knowledge in basic sciences and pathophysiology made us the only hospital that adopted the use of corticosteroids and total anticoagulation since the beginning of the pandemic, therapeutic measures in that uncertain and controversial momento.

Downloads

Download data is not yet available.

Author Biographies

  • Jorge Vélez-Páez, Universidad Central del Ecuador

    Doctor en medicina-Hospital Pablo Arturo Suárez

  • Mario Montalvo-Villagómez, Hospital Pablo Arturo Suárez

    Doctor en medicina

  • Fernando Jara-González, Hospital Pablo Arturo Suárez

    Doctor en medicina

  • Santiag Aguayo-Moscoso, Hospital Pablo Arturo Suárez

    Doctor en medicina

  • Wendy Tercero-Martínez, Hospital Pablo Arturo Suárez

    Doctor en medicina

  • Lenin Saltos-Íñiguez, Hospital Pablo Arturo Suárez

    Doctor en medicina

  • Patricio Vega-Luzuriaga, Instituto Nacional de Investigación en Salud Pública (INSPI)

    Licenciado en comunicación social

  • Jesús Dawaher, Hospital Pablo Arturo Suárez

    Doctor en medicina

References

Borghesi A, Zigliani A, Masciullo R et al. Radiographic severity index in COVID- 19 pneumonia: relationship to age and sex in 783 Italian patients, 27 March 2020, PREPRINT (Version 1) available at Research Square [+https://doi.org/10.21203/rs.3.rs-19498/v1+]

Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020

Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance 13 March 2020. World Health Organization. Disponible en: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected

Cochrane Iberoamérica, 2020, Infección bacteriana en pacientes con COVID-19

Disponible en https://es.cochrane.org/es/infecci%C3%B3n-bacteriana-en-pacientes-con-covid-19

Documento técnico. Manejo clínico del COVID-19: unidades de cuidados intensivos.19 de marzo de 2020. Ministerio de Salud, Gobierno de España. Disponible en: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Protocolo_manejo_clinico_uci_COVID-19.pdf

Elguea Echavarría Pedro Alejandro, 2019, Implementación de una escala de gravedad para la activación del equipo de respuesta rápida: NEWS 2 Disponible en https://www.medigraphic.com/pdfs/medcri/ti-2019/ti192h.pdf

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020.

Heyland DK, Dhaliwal R, Jiang X, Day AG. Identifying critically ill patients who benefit the most from nutrition therapy: the development and initial validation of a novel risk assessment tool. Critical Care. 2011;15(6):R268. Disponible en: https://www.criticalcarenutrition.com/docs/PEPuPCollaborative/Puntaje%20NUTRIC_PEP%20uP.pdf

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z. Clinical features of pacients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020 Jan 24.

Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020 Jan 31.

Jimenez A, Meraz Y. COVID-19: a aplanar la curva. Podcast de Medscape (16/03/2020). Disponible en https://espanol.medscape.com/verarticulo/5905155_1

Jin Y-H, Cai L, Cheng Z-S, Cheng H, Deng T, Fan Y-P, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research. 2020 Feb 6;7(1):4.

Jhons Hopkins University & Medicine, Coronavirus Resource Center. Disponible en https://coronavirus.jhu.edu/map.html

Judson SD et al., Viruses 2019, 11, 940; doi:10.3390/v11100940

Lamperti M, Bodenham AR, Pittiruti M, Blaivas M, Augoustides JG, Elbarbary M, et al. International evidence-based recommendations on ultrasound-guided vascular access. Intensive Care Med. 2012 Jul;38 (7):1105–17.

Liao, X., Wang, B. & Kang, Y. Novel coronavirus infection during the 2019–2020 epidemic: preparing intensive care units—the experience in Sichuan Province, China. Intensive Care Med 46, 357–360 (2020). https://doi.org/10.1007/s00134-020-05954-2

Massachusetts General Hospital COVID-19 Treatment Guidance. Version 1.0 3/17/2020. Disponible en: https://www.massgeneral.org/news/coronavirus/treatment-guidance

Ministerio de Salud Pública, Actualización de casos de coronavirus en Ecuador Disponible en https://www.salud.gob.ec/actualizacion-de-casos-de-coronavirus-en-ecuador/

OPS – OMS Prevención y control de infecciones y nuevo coronavirus (COVID-19): precauciones estándares y uso de equipos de protección personal Disponible en : https://www.paho.org/hq/index.php?option=com_docman&view=download&category_slug=materiales-presentaciones-webinars-9190&alias=51800-prevencion-y-control-de-infecciones-y-nuevo-coronavirus-covid-19-precauciones-estandares-y-uso-de-equipos-de-proteccion-personal-1&Itemid=270&lang=es

Phan LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HT, Le HQ, et al. Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam. New England Journal of Medicine. 2020.

Pérez-Padilla JR. La altitud modifica la relación entre la PaO2/FiO2 y el cortocircuito: impacto en la valoración de la lesión pulmonar aguda. Arch Bronconeumol. 2004 Oct 1;40(10):459–62.

Poston JT, Patel BK, Davis AM. Management of Critically Ill Adults With COVID-19. JAMA [Internet]. 2020 Mar 26 [cited 2020 Mar 28]; Available from: https://jamanetwork.com/journals/jama/fullarticle/2763879

RECOVERY Collaborative Group Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report. N Engl J Med (2020). July 17, 2020. DOI: 10.1056/NEJMoa2021436

Rahman A, Hasan RM, Agarwala R, Martin C, Day AG, Heyland DK. Identifying critically-ill patients who will benefit most from nutritional therapy: Further validation of the “modified NUTRIC” nutritional risk assessment tool. Clinical Nutrition. 2016 Feb 1;35(1):158–62.

Rahman A, Hasan RM, Agarwala R, Martin C, Day AG, Heyland DK. Identifying critically-ill patients who will benefit most from nutritional therapy: Further validation of the “modified NUTRIC” nutritional risk assessment tool. Clinical Nutrition. 2016 Feb 1;35(1):158–62.

Shi C, Wang C, Wang H, Yang C, Cai F, Zeng F et al. The potential of low molecular weight heparin to mitigate cytokine storm in severe covid-19 patients: a retrospective clinical study. medRxiv 2020.03.28.20046144; doi: https://doi.org/10.1101/2020.03.28.20046144

Tinku Joseph (India); Dr. Mohammed Ashkan (Irán).INTERNATIONAL PULMONOLOGIST’S CONSENSUS ON COVID-19 Chief Editors Dr. 2020. Disponible en: https://www.unah.edu.hn/dmsdocument/9674-consenso-internacional-de-neumologos-sobre-covid-19-version-ingles

Tyrrell DA, Bynoe ML. Cultivation of viruses from a high proportion of patients with colds. Lancet. 1966;1:76 –77. Disponible en: https://pubmed.ncbi.nlm.nih.gov/4158999/

Toledo J. Prevención y control de infecciones y nuevo coronavirus (COVID-19): precauciones estándares y uso de equipos de protección personal. Feb 19, 2020.OPS/OMS. Disponible en https://bit.ly/2HDK2bg

Vezzani A, Brusasco C, Palermo S, Launo C, Mergoni M, Corradi F. Ultrasound localization of central vein catheter and detection of postprocedural pneumothorax: an alternative to chest radiography. Crit Care Med. 2010 Feb;38(2):533–8.

Word Health Organization (2020). National use of personal protective equipment for coronavirus disease 2019 (COVID-19) Interim guidance. 27 February 2020. Disponible en https://apps.who.int/iris/handle/10665/331498.

Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med [Internet]. 2020

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Eng J Med. 2020.

Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, Marzo 2020

Published

2021-01-15

Issue

Section

Artículos Científicos

How to Cite

Management guide for COVID19 patients in intensive therapy - Hospital Pablo Arturo Suárez. (2021). CIENCIA UNEMI, 14(35), 92-107. https://doi.org/10.29076/issn.2528-7737vol14iss35.2021pp92-107p